These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 31965045)

  • 1. Prognostic Nomogram For Locoregionally Advanced Nasopharyngeal Carcinoma.
    Jiang Y; Qu S; Pan X; Huang S; Zhu X
    Sci Rep; 2020 Jan; 10(1):861. PubMed ID: 31965045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognosis viewing for nasopharyngeal carcinoma treated with intensity-modulated radiation therapy: application of nomogram and decision curve analysis.
    Fei Z; Qiu X; Li M; Chen C; Li Y; Huang Y
    Jpn J Clin Oncol; 2020 Feb; 50(2):159-168. PubMed ID: 31711182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic nomogram for patients with Nasopharyngeal Carcinoma incorporating hematological biomarkers and clinical characteristics.
    Li J; Chen S; Peng S; Liu Y; Xing S; He X; Chen H
    Int J Biol Sci; 2018; 14(5):549-556. PubMed ID: 29805306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Nomogram for Patients with Nasopharyngeal Carcinoma after Intensity-Modulated Radiotherapy.
    Wu S; Xia B; Han F; Xie R; Song T; Lu L; Yu W; Deng X; He Q; Zhao C; Xie C
    PLoS One; 2015; 10(8):e0134491. PubMed ID: 26248338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a Nomogram Model for Treatment of Nonmetastatic Nasopharyngeal Carcinoma.
    Zhang LL; Xu F; Song D; Huang MY; Huang YS; Deng QL; Li YY; Shao JY
    JAMA Netw Open; 2020 Dec; 3(12):e2029882. PubMed ID: 33306119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of detailed MR imaging report of primary tumor and lymph nodes on prognostic nomograms for nasopharyngeal carcinoma after intensity-modulated radiotherapy.
    Wan Y; Tian L; Zhang G; Xin H; Li H; Dong A; Liang Y; Jing B; Zhou J; Cui C; Chen M; Sun Y; Xie C; Liu L; Shao Y
    Radiother Oncol; 2019 Feb; 131():35-44. PubMed ID: 30773185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a nomogram for predicting the survival of patients with non-metastatic nasopharyngeal carcinoma after curative treatment.
    Liang W; Shen G; Zhang Y; Chen G; Wu X; Li Y; Li A; Kang S; Yuan X; Hou X; Huang P; Huang Y; Zhao H; Tian Y; Zhao C; Zhang L
    Chin J Cancer; 2016 Nov; 35(1):98. PubMed ID: 27887636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. External validity of a prognostic nomogram for locoregionally advanced nasopharyngeal carcinoma based on the 8th edition of the AJCC/UICC staging system: a retrospective cohort study.
    OuYang PY; You KY; Zhang LN; Xiao Y; Zhang XM; Xie FY
    Cancer Commun (Lond); 2018 Sep; 38(1):55. PubMed ID: 30176932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proposal of a Pretreatment Nomogram for Predicting Local Recurrence after Intensity-Modulated Radiation Therapy in T4 Nasopharyngeal Carcinoma: A Retrospective Review of 415 Chinese Patients.
    Zhang LL; Li YY; Hu J; Zhou GQ; Chen L; Li WF; Lin AH; Ma J; Qi ZY; Sun Y
    Cancer Res Treat; 2018 Oct; 50(4):1084-1095. PubMed ID: 29141396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multidimensional nomogram combining overall stage, dose volume histogram parameters and radiomics to predict progression-free survival in patients with locoregionally advanced nasopharyngeal carcinoma.
    Yang K; Tian J; Zhang B; Li M; Xie W; Zou Y; Tan Q; Liu L; Zhu J; Shou A; Li G
    Oral Oncol; 2019 Nov; 98():85-91. PubMed ID: 31569054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A nomogram for predicting late radiation-induced xerostomia among locoregionally advanced nasopharyngeal carcinoma in intensity modulated radiation therapy era.
    Yang K; Xie W; Zhang X; Wang Y; Shou A; Wang Q; Tian J; Yang J; Li G
    Aging (Albany NY); 2021 Jul; 13(14):18645-18657. PubMed ID: 34282056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Validation of Web-Based Nomograms to Precisely Predict Survival Outcomes of Non-metastatic Nasopharyngeal Carcinoma in an Endemic Area.
    Yao JJ; Lin L; Gao TS; Zhang WJ; Lawrence WR; Ma J; Sun Y
    Cancer Res Treat; 2021 Jul; 53(3):657-670. PubMed ID: 33285052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic nomogram for refining the prognostication of the proposed 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy.
    Pan JJ; Ng WT; Zong JF; Lee SW; Choi HC; Chan LL; Lin SJ; Guo QJ; Sze HC; Chen YB; Xiao YP; Kan WK; O'Sullivan B; Xu W; Le QT; Glastonbury CM; Colevas AD; Weber RS; Lydiatt W; Shah JP; Lee AW
    Cancer; 2016 Nov; 122(21):3307-3315. PubMed ID: 27434142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic nomogram to predict the distant metastasis after intensity-modulated radiation therapy for patients with nasopharyngeal carcinoma.
    Mi JL; Xu M; Liu C; Wang RS
    Medicine (Baltimore); 2021 Nov; 100(47):e27947. PubMed ID: 34964774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Competing risk nomograms for nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: A big-data, intelligence platform-based analysis.
    Huang XD; Zhou GQ; Lv JW; Zhou HQ; Zhong CW; Wu CF; Zheng ZQ; He XJ; Peng L; Ma J; Sun Y
    Radiother Oncol; 2018 Nov; 129(2):389-395. PubMed ID: 30270098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A nomogram based on nutritional and inflammatory parameters to predict DMFS and identify beneficiaries of adjuvant chemotherapy in IVA-stage nasopharyngeal carcinoma.
    Pan Y; Chen Z; Hong W; Huang Z; Li Y; Cai S; Lai J; Lu J; Qiu S
    BMC Cancer; 2024 May; 24(1):578. PubMed ID: 38734620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A nomogram based on circulating CD8
    Yan C; Yang G; Zhang C; Chen K; Sun Y; Liang Z; Lai L; Li L; Qu S; Zhu XD
    Radiat Oncol; 2024 Aug; 19(1):108. PubMed ID: 39138513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival impact of radiotherapy interruption in nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: A big-data intelligence platform-based analysis.
    Yao JJ; Zhang F; Gao TS; Zhang WJ; Lawrence WR; Zhu BT; Zhou GQ; Ma J; Wang SY; Sun Y
    Radiother Oncol; 2019 Mar; 132():178-187. PubMed ID: 30448002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic score models for survival of nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy and chemotherapy.
    Zeng L; Guo P; Li JG; Han F; Li Q; Lu Y; Deng XW; Zhang QY; Lu TX
    Oncotarget; 2015 Nov; 6(36):39373-83. PubMed ID: 26415223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a nomogram for predicting long-term overall survival in nasopharyngeal carcinoma: A population-based study.
    Wu J; Zhou Q; Pan Z; Wang Y; Hu L; Chen G; Wang S; Lyu J
    Medicine (Baltimore); 2020 Jan; 99(4):e18974. PubMed ID: 31977914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.